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Retina Tomograph (HRT) measurements of the optic
disc are associated with the development of open-angle
glaucoma (OAG) in individuals with ocular hypertension
in the European Glaucoma Prevention Study (EGPS).
 DESIGN: Retrospective analysis of a prospective, ran-
domized, multicenter, double-masked, controlled clinical
trial.
 METHODS: There were 489 participants in the HRT
Ancillary Study to the EGPS. Each baseline HRT param-
eter was assessed in univariate and multivariate propor-
tional hazards models to determine its association with the
development of OAG. Proportional hazards models were
used to identifyHRT variables that predicted which partic-
ipants in the EGPS had developed OAG. Development of
OAG was based on visual field and/or optic disc changes.
 RESULTS: At a median follow-up time of about 5 years,
61 participants developed OAG. In multivariate analyses,
adjusting for randomization arm, age, baseline IOP, cen-
tral corneal thickness, pattern standard deviation, and
HRT disc area, the following HRT parameters were asso-
ciated with the development of OAG: the ‘‘outside normal
limits’’ classification of the Frederick Mikelberg (FSM)
discriminant function (hazard ratio [HR] 2.51, 95% con-
fidence interval [CI]: 1.45–4.35), larger mean cup depth
(HR 1.64, 95% CI: 1.21–2.23), cup-to-disc area ratio
(HR 1.43, 95% CI: 1.14–1.80), linear cup-to-disc ratio
(HR 1.43, 95% CI: 1.13–1.80), cup area (HR 1.33,
95% CI: 1.08–1.64), smaller rim area (HR 1.33, 95%
CI: 1.07–1.64), larger cup volume (HR 1.30, 95% CI:
1.05–1.61), smaller rim volume (HR 1.25, 95% CI:
1.01–1.54), larger maximum cup depth (HR 1.18, 95%
CI: 1.01–1.36), and cup shape measure (HR 1.18, 95%
CI: 1.01–1.36).r publication Oct 27, 2014.
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P
REVENTION OF BLINDNESS FROM GLAUCOMA
remains one of the major goals in ophthalmology.
At present the therapeutic strategies are mainly
based on a medical or a surgical approach aimed at
decreasing intraocular pressure (IOP). Ocular hypertension
(OHT) has been recognized as the most important risk fac-
tor for the development of open-angle glaucoma (OAG)1–6
and, as of today, is the only factor that can be significantly
influenced by medication or surgery. Among other risk
factors that are deemed important in the genesis of the
disease, such as age, race, family history, and low diastolic
perfusion pressure,3–9 only the latter can hypothetically
benefit from a multidisciplinary therapeutic approach.
A strategy aimed at preventing the onset of OAG among
patients with OHT10 is best based on the identification of
predictive factors. Older age, higher IOP, larger vertical or
horizontal cup-to-disc (C/D) ratio, greater pattern standard
deviation (PSD), and thinner central corneal thickness
(CCT) at baseline have been found to be predictors for
the onset of OAG in the Ocular Hypertension Treatment
Study (OHTS)11 and in theEuropeanGlaucomaPrevention
Study (EGPS).12 By merging the datasets of the OHTS and
the EGPS it has been possible to provide a risk calculator for
the development of primary open-angle glaucoma (POAG)
within 5 years, whichmay estimate the individual risk profile
and be helpful to the clinician in establishing the manage-
ment of OHT in each specific patient.13,14
Both the OHTS and the EGPS have conducted an ancil-
lary study in a subset of the original sample based on the use
of theHeidelbergRetinaTomograph(HRT) inorder to assess
whetherHRT results could be predictive for the development
of OAG. From the introduction of the first dedicated HRT
confocal scanning laser ophthalmoscope (CSLO) in 1989
for disc imaging and topography,15 the overall agreement
based on the results of several studies is thatHRTmay identify265ALL RIGHTS RESERVED.
early signs of structural glaucomatous damage.16–33 TheHRT
Ancillary Study of the OHTS has confirmed these
observations, suggesting that the clinical use of HRT in
OHT patients may predict the development of POAG.34–36
This report describes the HRT predictive parameters for
development of OAG among the OHT patients enrolled in
the EGPS.37 Given the similarities between the protocols
for the OHTS34 and the EGPS,37 our results may add to
the refinement of a more accurate identification of OHT
patients who may warrant treatment with ocular hypoten-
sive medications, and are the ground for the ongoing
OHTS-EGPS HRT Collaborative Study.METHODS
THE EGPS WAS A MULTICENTER RANDOMIZED, DOUBLE-
masked, placebo-controlled clinical trial.38 Since it was
planned in 1995, it started thereafter, and it was not
ongoing by December 2007, the EGPS is not registered
either at ‘‘clinicaltrials.gov’’ or at ‘‘controlled-trials.com.’’
The design and methods of the EGPS were previously
described39 and are summarized as follows. This HRT
Ancillary Study to the EGPS is a retrospective analysis of
the original prospective clinical trial.
The protocol was approved by the ethical review commit-
tee of each participating clinic, and each patient gave his or
her informed consent to be enrolled in the study. In brief,
1081 individuals with IOP >_22 mm Hg in at least 1 eye and
no evidence of glaucomatous damage were randomized to
either dorzolamide or placebo. Four patients who were found
to have glaucoma at the time of randomization were discon-
tinued from the study and excluded from further analyses,
leaving a total of 1077 patients. The primary outcome was
the development of a reproducible visual field change from
baseline, or a clinically detectable optic disc change from
baseline as determinedby2of 3 independent evaluators.40Vi-
sual field (VF) and optic disc changes were identified by
maskedcertified evaluators at thecentral coordinating center,
and the confirmation that the endpoint was attributable to
OAG was determined after masked review of the clinical
charts. Both visual field and optic disc photographs were
performed every 6 months. Worsening of visual field was
reached when at least 1 of the following criteria was met:
(1) >_3 horizontally or vertically adjacent points that differ
>_5 dB frombaseline, (2)>_2 horizontally or vertically adjacent
points that differ >_10 dB from baseline, (3) difference of >_10
dBacross nasal horizontalmeridian at>_2 adjacent points.The
loss had to be not attributable to other pathologies.
The sensitivity loss was defined relative to the baseline
(normal) values of each patient. The superior and inferior
rows of the physiologic blind spot were excluded from the
field evaluation. Tomeet the criteria that defined the occur-
rence of visual field endpoint, the patient had to repeat the
VF testing within 30 days. If the defect was confirmed in the266 AMERICAN JOURNAL OFsame test locations, the patient had to repeat a third VF test.
If the defect was confirmed again, the VF endpoint was
considered as met (the 3 VF results had to be consecutive).
In case of questionable worsening the patient continued the
study and repeated the VF test at the next follow-up visit.
Worsening of the optic disc was defined as a visually recog-
nizable (on stereophotographs) narrowing of the neuroreti-
nal rim area (localized or diffuse) not attributable to
photographic artifacts. This was detected by comparing
follow-up stereoscopic optic disc slides with baseline stereo-
scopic optic disc slides. An optic disc endpoint was reached
when 2 out of 3 optic disc reading centers independently
determined worsening. If the worsening appeared question-
able, the patient continued in the study and pictures were
taken again at the next follow-up visit.
A detailed collection of clinical data was obtained from
each participant by self-report. This information included
ocular and medical history and current use of medication.
Medical history was obtained by self-report from the partic-
ipant.
Baseline demographic and clinical information were
collected for each participant prior to randomization. The
baseline and follow-up visits included assessment of refraction
and visual acuity using the standard procedures at each given
office; Goldmann applanation tonometry performed and
recorded by a single investigator between 8:00 and 11:00
AM (ie, at least 1 but not more than 3 hours after the
last dose of study medication); complete ophthalmologic
examination including gonioscopy, automated static peri-
metry with aHumphrey (Carl ZeissMeditec, Dublin, Califor-
nia, USA) or Octopus (Haag-Streit AG, Koeniz-Berne,
Switzerland) instrument using a central 30-degree program
with threshold double-crossing strategy; and color slide ste-
reophotography of the optic disc. Myopia was defined as a
spherical equivalent of1.0 diopter (D) or more. Horizontal
and vertical C/D ratios by contour were estimated visually
from stereoscopic optic disc photographs by masked certified
readers. C/D ratio asymmetry was calculated by subtracting
the C/D ratio value of 1 eye from that of the other eye.
In the EGPS, 241 out of 1077 patients underwent Octopus
visual field evaluations, which calculate ‘‘loss variance’’
insteadof ‘‘pattern standard deviation.’’ Therefore, the indices
of the Octopus were converted to the indices of the
Humphrey system. One approach could have been the algo-
rithms reported by Zeyen and associates,41 but these were
derived from glaucomatous visual fields. Based on personal in-
formation (Heijl A, and Johnson C, oral communication,
September 1, 2005), the mean defect, loss variance, and
corrected loss variance of theOctopus systemwere converted
to the mean deviation (MD), PSD, and corrected pattern
standard deviation (CPSD) of the Humphrey visual field
testing. This was performed by changing the sign in front of
the value of mean defect and by calculating the square root
of the loss variance andcorrected loss variance, respectively.12
Although not included in the original protocol of the
study, CCT measurements were taken during the trial inFEBRUARY 2015OPHTHALMOLOGY
a large sample of the patients: 429 in the dorzolamide group
(80.0%) and 425 in the placebo group (78.5%).42 CCT was
performed using the same pachymeter employed in the
OHTS (DGH-500 Pachette; DGH Technologies, Exton,
Pennsylvania, USA)43 following a standard procedure in
all the centers, which included the use of topical anesthesia
and the acquisition of 5 measurements in both eyes. The
average of the mean of the 5 measurements of the 2 eyes
was considered for analysis. When only 1 eye was included
in the study, the mean of the 5 measurements of that eye
was considered for the analysis. This measurement was
begun in 2002, 3 years after the randomization of the last
patient enrolled in the study.
In the EGPS, a total of 106 out of 1077 patients devel-
oped OAG over the course of the trial. However, among
the patients who discontinued the study and were followed
according to the same protocol until the end of the study
(293 patients), 14 developed a visual field (6) or optic
disc (8) endpoint after the discontinuation for a total of
120 patients who developed OAG, regardless of the time
that OAG occurred.
In this publication, glaucoma is always referred to as
OAG for consistency throughout themanuscript. It is noted
that the EGPS allowed for the inclusion of patients affected
by pigment dispersion syndrome (PDS) or pseudoexfolia-
tion syndrome (PEX), which may lead to secondary OAG.
 HEIDELBERG RETINA TOMOGRAPH: The Heidelberg
Retina Tomograph (HRT; Heidelberg Engineering GmbH,
Heidelberg, Germany) is a confocal scanning laser device
that uses a 670-nm diode laser to obtain 2- and 3-
dimensional images of the optic nerve head and the peripa-
pillary retina.15 HRT examinations within the EGPS started
at the baseline examination. TheHRT images were obtained
every 6 months or at least annually. In all eyes, 10-degree
HRT images were acquired at baseline and throughout the
study using the older hardware version (HRT ‘‘classic’’). A
topographic image is built from a series of 32 consecutive op-
tical sections, each consisting of 256 3 256 pixels. A mean
image is generated by 3 consecutive scans. A minimum of
2 but preferably 3 images were obtained, and a mean image
was created for each eye. Keratometry measurements were
used to correct for magnification error. For analysis purposes,
all HRT data were analyzed in software version 3.0 (Heyex
platform).
Assessment of image quality was performed by means of
the automatic quality control ‘‘Auto QC’’ feature of the
software according to the following recommended criteria
to reject images: underexposure, severe overexposure, focus
greater than or equal to 75 diopters, scan depth too small,
scan depth too high (equal to or greater than 1 mm), stan-
dard deviation greater than 50mm (mean pixel height stan-
dard deviation). The optic disc margin, defined as the inner
margin of the scleral ring, was outlined on the mean topog-
raphy image by 1 experienced examiner. Each outline
of the optic disc was reviewed for accurate placement byVOL. 159, NO. 2 EXOGENOUS FUNGAL ENDOPHTHALMa second experienced examiner (with differences of
opinion resolved by consensus). The reference plane was
automatically determined at 50 mm posterior to the mean
retinal height between 350 degrees and 356 degrees (papil-
lomacular bundle) along the contour line.
Automatic HRT image quality assessment and drawing
of the contour line took place at the EGPS HRT Reading
Center at the Department of Ophthalmology, University
Medical Center of Mainz, Germany. A second indepen-
dent image quality control step was performed at the
OHTS CSLO Reading Center, University of California,
San Diego (San Diego, California, USA), with the goal
of including as many ‘‘good-quality’’ scans as possible, using
the same review criteria that had been used for the OHTS
CSLO Ancillary Study.34–36
The following stereometric parameters and multidiscri-
minant functions were calculated and evaluated: disc
area; cup area; rim area; cup volume; rim volume; C/D
area; linear C/D; mean cup depth; maximum cup depth;
cup shape measure; height variation contour (HVC);
retinal nerve fiber layer (RNFL) cross-sectional area;
mean RNFL thickness; reference plane height; standard de-
viation; Frederick Mikelberg’s discriminant function
(FSM), which corresponds to the ‘‘HRT classification’’;
Reinhard Burk’s discriminant function (RB); Moorfields
regression analysis (MRA); and the Glaucoma Probability
Score (GPS). The FSM uses a formula that takes into ac-
count rim volume, cup shape measure, and height variation
contour, adjusting for age.16 The RB uses the same param-
eters as the FSM, but weights them differently.25 Both
discriminant analyses classify the image as being normal
or outside normal limits. MRA compares global and secto-
rial rim area (after adjusting for disc area) to a normative
database.21 MRA is classified as ‘‘within normal limits’’ if
a given rim area is equal to or greater than confidence inter-
val at 95% (95% CI), ‘‘borderline’’ if it is between 95% and
99.9% CI, and ‘‘outside normal limits’’ if it is >99.9% CI.
GPS uses 2 measurements of the peripapillary retinal nerve
fiber layer shape (horizontal and vertical RNFL curvature)
and 3 measurements of the optic nerve head shape (cup
size, cup depth, and rim steepness) for input into a vector
machine-learning classifier that estimates the probability
of having damage consistent with glaucoma.24 Both MRA
and GPS classify the image as being within normal limits,
borderline, or outside normal limits. For the sake of the
analysis, results classified as being ‘‘borderline’’ have been
considered as being ‘‘within normal limits.’’
 STATISTICALANALYSIS: When both eyes were included
in the study (366 patients),13 for some eye-specific vari-
ables, the mean for each eye (eg, the mean of the 2 IOP
or the 5 CCTmeasurements) was calculated and then these
2 values were averaged to determine the baseline predictive
factor. For other eye-specific variables, the second obtained
measurement (eg, the second baseline visual field test) or
the only available measurement (eg, the C/D ratios) was267ITIS ANTIFUNGAL SUSCEPTIBILITIES
TABLE 1. Baseline Demographic Characteristics by Open-
Angle Glaucoma Status (Average of the Eyes)
Characteristic Normal
Number (%)
AllOAG Endpoint
Sex
Female 232 (87.55) 33 (12.45) 265 (100)
Male 196 (87.50) 28 (12.50) 224 (100)
High blood pressure
No 280 (88.89) 35 (11.11) 315 (100)
Yes 148 (85.06) 26 (14.94) 174 (100)
Cardiovascular diseases
No 372 (88.78) 47 (11.22) 419 (100)
Yes 56 (80.00) 14 (20.00) 70 (100)
Diabetes
No 399 (87.31) 58 (12.69) 457 (100)
Yes 29 (90.63) 3 (9.38) 32 (100)
Diuretics
No 380 (88.99) 47 (11.01) 427 (100)
Yes 48 (77.42) 14 (22.58) 62 (100)
ACE inhibitors
No 321 (88.43) 42 (11.57) 363
Yes 107 (84.92) 19 (15.08) 126
Calcium channel blockers
No 366 (88.41) 48 (11.59) 414 (100)
Yes 62 (82.67) 13 (17.33) 75 (100)
Beta blockers
No 359 (87.60) 48 (12.40) 387 (100)
Yes 89 (87.25) 13 (12.75) 102 (100)
FSM
Normala 337 (90.59) 35 (9.41) 372 (100)
Abnormalb 91 (77.78) 26 (22.22) 117 (100)
GPS
Normala 349 (88.35) 46 (11.65) 395 (100)
Abnormalb 63 (82.89) 13 (17.11) 76 (100)
MRA
Normala 394 (88.74) 50 (11.26) 444 (100)
Abnormalb 34 (75.56) 11 (24.44) 45 (100)
ACE ¼ angiotensin-converting enzyme; FSM ¼ Frederick
Mikelberg discriminant function; GPS ¼ Glaucoma Probability
Score; MRA ¼ Moorfields regression analysis; OAG ¼ open-
angle glaucoma
aWithin normal limits þ borderline.
bOutside normal limits.used and then the values of the 2 eyes were averaged to
determine the baseline predictive factor. When 1 eye
only was included in the study (123 patients), only the
data from the included eye were used. When both eyes
were included in the study, the mean of the 2 eyes was
calculated for each HRT parameter. In the case of FSM,
RB, MRA, and GPS, if 1 of the 2 included eyes was outside
normal limits then the classification for study purposes was
‘‘outside normal limits.’’ When only 1 eye was included in
the study, only the data from the included eye were used.
Cox proportional hazards models as implemented in the
PHREG program in the SAS statistical software (SAS Insti-
tute Inc, Cary, North Carolina, USA) were used to estimate
and test factors for their association with the development of
OAG. The analysis sample for the proportional hazards
models consisted of 61 randomized participants who devel-
oped POAG and 428 randomized patients who did not
develop OAG before the end of the trial (September
2003). Median participant follow-up was 59.5 months, or
about 5 years. Proportional hazard models were used for uni-
variate and multivariate analysis. Variables that were found
to be associated with OAG development in the univariate
analysis (P < .1) were considered for the multivariate anal-
ysis. Multivariate Cox proportional hazards models were
evaluated in the entire study sample using the treated arm
as stratification variables. Two multivariate analyses were
performed for each singleHRTparameter thatwas associated
with OAG development in univariate analysis, the former
also including in the model age, CCT, baseline mean IOP,
and PSD, which are the baseline predictive factors for the
development of OAG found in the EGPS,12 and the latter
including in the model the same baseline factors and HRT
disc area, given the previously reported high correlation be-
tween several HRT parameters and HRT disc area.37,44–47
Vertical C/D ratio, which is also a significant predictive
factor for OAG in the EGPS,12 was not included in any anal-
ysis given the consistency of HRT and ophthalmoscopic
evaluations, obviously performed on the same anatomic
structure (the optic disc).37 With a stratified Cox model, a
proportional hazard structure is assumed to hold within
each stratum.The relative effect of each predictor is assumed
the same across strata, unless there is a significant strata-by-
covariate interaction, which implies that the effect of the
particular covariate differs within strata. One disadvantage
of using a stratifiedmodel is that an effect of the stratification
covariate cannot be estimated in the model, at least in the
sense of a coefficient estimate. Since we were not interested
inestimating the effect of treatment, but only in taking it into
account when estimating the effect of other variables, the
stratified model seemed the most appropriate method to be
used, as also adopted by others (OHTS).11 Results are
expressed as hazard ratios (HRs) with 95%CIs Statistical sig-
nificance was defined as P < .05 for a bilateral test.
A 2-sided log-rank test was performed at the 5% signifi-
cance level. The primary variable was the length of time to
develop glaucomatous damage, that is, the time from268 AMERICAN JOURNAL OFrandomization to first confirmed occurrence of a worsened
visual field or a worsened optic disc. The univariate differ-
ence between a baseline abnormal or normal HRT exami-
nation with respect to the primary variable was assessed
using survival analysis.RESULTS
OF THE 1077 PARTICIPANTS IN THE EGPS STUDY, 489 (45.4%)
were included in the HRT study, accounting for 4052FEBRUARY 2015OPHTHALMOLOGY
TABLE 2. Baseline Demographic and Ocular Characteristics by Open-Angle Glaucoma Status (Average of the Eyes)
Characteristic
Normal OAG Endpoint All
Sample Size Mean (SD) Sample Size Mean (SD) Sample Size Mean (SD)
Age 428 56.70 (9.57) 61 61.74 (8.87) 489 57.33 (9.62)
Baseline IOP 428 23.62 (1.52) 61 24.04 (1.78) 489 23.68 (1.56)
Refraction 428 0.21 (1.89) 61 0.56 (1.80) 489 0.26 (1.88)
MD 428 0.44 (1.44) 61 0.91 (1.33) 489 0.50 (1.43)
PSD 428 1.97 (0.58) 61 2.07 (0.56) 489 1.98 (0.58)
CPSD 428 1.05 (0.66) 61 1.17 (0.59) 489 1.07 (0.66)
Best-corrected visual acuity 428 0.02 (0.06) 61 0.02 (0.04) 489 0.02 (0.06)
CCT 351 578.82 (36.88) 57 560.87 (29.03) 408 576.31 (36.39)
Vertical C/D 428 0.34 (0.14) 61 0.40 (0.13) 489 0.35 (0.14)
Vertical C/D asymmetry 428 0.05 (0.06) 61 0.09 (0.08) 489 0.05 (0.07)
Keratometry 428 7.68 (0.17) 61 7.69 (0.13) 489 7.68 (0.17)
HRT parameters
Disc area 428 2.05 (0.42) 61 2.02 (0.40) 489 2.04 (0.42)
Cup area 428 0.51 (0.38) 61 0.62 (0.38) 489 0.53 (0.38)
Rim area 428 1.53 (0.29) 61 1.40 (0.34) 489 1.52 (0.30)
Cup volume 428 0.12 (0.13) 61 0.16 (0.15) 489 0.13 (0.14)
Rim volume 428 0.41 (0.15) 61 0.36 (0.14) 489 0.41 (0.15)
C/D area 428 0.24 (0.14) 61 0.29 (0.14) 489 0.25 (0.14)
C/D linear 428 0.45 (0.16) 61 0.52 (0.15) 489 0.46 (0.16)
Cup depth 428 0.21 (0.09) 61 0.25 (0.10) 489 0.22 (0.09)
Maximum cup depth 428 0.57 (0.20) 61 0.63 (0.21) 489 0.58 (0.20)
Cup shape measurement 428 0.17 (0.07) 61 0.15 (0.07) 489 0.17 (0.07)
HVC 428 0.39 (0.09) 61 0.39 (0.09) 489 0.39 (0.09)
RNFL thickness 428 0.24 (0.06) 61 0.23 (0.07) 489 0.24 (0.06)
RNFL CSA 428 1.22 (0.33) 61 1.14 (0.33) 489 1.21 (0.33)
Reference height 428 0.30 (0.09) 61 0.30 (0.09) 489 0.30 (0.09)
SD 428 17.89 (7.14) 61 18.79 (7.20) 489 18.00 (7.14)
RB formula 428 1.29 (0.84) 61 1.15 (0.83) 489 1.27 (0.84)
CCT ¼ central corneal thickness; C/D ¼ cup-to-disc; CPSD ¼ corrected pattern standard deviation; CSA ¼ cross-sectional area; HVC ¼
height variation contour; IOP ¼ intraocular pressure; MD ¼mean deviation; OAG ¼ open-angle glaucoma; PSD ¼ pattern standard deviation;
RB ¼ Reinhard Burk; RNFL ¼ retinal nerve fiber layer; SD ¼ standard deviation.good-quality HRT images taken during the study. Images
were taken in both eyes in 366 participants whereas they
were taken in 1 eye only (the same included in the clinical
trial) in 123 participants, for a total of 855 eyes. As the
EGPS clinical trial began before the availability of the
confocal scanning laser ophthalmoscope at all the sites
involved in the EGPS HRT substudy, not all participants
completed their imaging at the EGPS baseline visit. Of
the 489 participants with good-quality images included in
this study, 177 (36.2%) had images obtained at the baseline
visit, 76 (15.5%) at the 6- or 12-month visit, 122 (24.9%)
at the 18- or 24-month visit, 44 (9%) at the 30- or 36-
month visit, and 70 (14.3%) later. Among the 312 partic-
ipants who were not evaluated by means of HRT at base-
line, the mean (6SD) time between randomization and
first HRT examination was 2.06 6 1.3 years in 267 partic-
ipants not developing OAG, and 1.59 6 0.56 years in 45
participants who developed OAG.
Demographic characteristics of the subjects partici-
pating and nonparticipating in the HRT study have beenVOL. 159, NO. 2 EXOGENOUS FUNGAL ENDOPHTHALMpreviously published.37 Table 1 and Table 2 report those
of the 489 OHT patients by OAG status. At a median
follow-up of 59.5 months 61 patients developed OAG,
defined by an optic disc endpoint in 27 and by a visual field
endpoint in 34 cases. Fifty-two endpoints were reached dur-
ing the trial and 9 endpoints were reached after discontin-
uation of the patient from the clinical trial.
Themultivariate analysis of the baseline predictive factors
previously reported by the EGPS12 in this subset of the orig-
inal population shows that the HRs (95% CI) for age, IOP,
CCT, vertical C/D ratio, and PSD are 1.52 (1.05–2.19),
1.10 (0.93–1.30), 1.71 (1.21–2.41), 1.88 (1.38–2.58), and
1.53 (0.92–2.56), respectively. Univariate HRs with 95%
CIs are reported for each putative HRT predictive factor
for the development of OAG in Table 3. In univariate ana-
lyses, baseline HRT parameters significantly predictive of
the development of OAG were rim area, cup area, rim vol-
ume, C/D area ratio, C/D linear ratio, cup depth, maximum
cup depth, cup shape measure, FSM function outside normal
limits, and MRA result outside normal limits.269ITIS ANTIFUNGAL SUSCEPTIBILITIES
TABLE 3. Univariate Hazard Ratios and 95% Confidence
Intervals for the Development of Open-Angle Glaucoma
(Average of the Eyes)
HRT Parameter HR (95% CI) P
Disc area (per 0.4 mm2 greater) 0.95 (0.75–1.21) .70
Cup area (per 0.3 mm2 greater) 1.12 (1.00–1.25) .057
Rim area (per 0.2 mm2 greater) 0.75 (0.62–0.90) .002
Cup volume (per 0.1 mm2 greater) 1.16 (1.00–1.35) .045
Rim volume (per 0.1 mm3 greater) 0.79 (0.65–0.96) .016
C/D area (per 0.1 greater) 1.29 (1.09–1.53) .003
C/D linear (per 0.1 greater) 1.28 (1.08–1.52) .005
Cup depth (per 0.1 mm greater) 1.46 (1.14–1.88) .003
Max cup depth (per 0.1 mm greater) 1.14 (1.01–1.30) .042
Cup shape measure (per 0.1 greater) 1.75 (1.19–2.57) .004
HVC (per 0.1 greater) 0.97 (0.73–1.28) .82
RNFL thickness (per 0.1 greater) 0.73 (0.49–1.09) .12
RNFL CSA (per 0.3 mm2 greater) 0.94 (0.86–1.01) .10
Reference height (per 0.1 mm greater) 1.05 (0.80–1.40) .70
RB outside normal limits 0.98 (0.95–1.40) .26
FSM outside normal limits 2.44 (1.47–4.06) .001
GPS global outside normal limits 1.44 (0.78–2.66) .24
MRA result outside normal limits 2.29 (1.19–4.40) .013
C/D ¼ cup-to-disc; CI ¼ confidence interval; CSA ¼ cross-
sectional area; FSM¼ FrederickMikelberg discriminant function;
GPS ¼ Glaucoma Probability Score; HR ¼ hazard ratio; HRT ¼
Heidelberg Retina Tomograph; HVC ¼ height variation contour;
MRA¼Moorfields regression analysis; OAG ¼ open-angle glau-
coma; RB¼ Reinhard Burk discriminant function; RNFL¼ retinal
nerve fiber layer.
TABLE 4. Multivariate Hazard Ratios and 95% Confidence
Intervals for the Development of Open-Angle Glaucoma
(Average of the Eyes), Including the Model Age, Baseline
Intraocular Pressure, Central Corneal Thickness, and Pattern
Standard Deviation
HRT Parameter HR (95% CI) P
Cup area (per 0.3 mm2 greater) 1.11 (0.98–1.25) .095
Rim area (per 0.2 mm2 greater) 0.78 (0.63–0.95) .014
Cup volume (per 0.1 mm2 greater) 1.16 (0.99–1.36) .07
Rim volume (per 0.1 mm3 greater) 0.80 (0.65–0.99) .041
C/D area (per 0.1 greater) 1.25 (1.04–1.49) .015
C/D linear (per 0.1 greater) 1.26 (1.05–1.61) .013
Cup depth (per 0.1 mm greater) 1.46 (1.11–1.93) .007
Maximum cup depth
(per 0.1 mm greater)
1.15 (1.00–1.32) .052
Cup shape measure (per 0.1 greater) 1.65 (1.08–2.52) .009
FSM outside normal limits 2.40 (1.40–4.09) .001
GPS global outside normal limits 0.93 (0.48–1.80) .82
MRA result outside normal limits 1.75 (0.87–3.51) .11
Age (per 10 y older) 1.41–1.58 <.05
Baseline IOP (per 1 mm Hg higher) 1.18–1.22 <.05
CCT (per 40 mm thinner) 1.51–1.59 <.05
PSD (per 0.2 dB greater) 1.04–1.19 >.05
CCT ¼ central corneal thickness; C/D ¼ cup-to-disc; CI ¼
confidence interval; FSM ¼ Frederick Mikelberg discriminant
function; GPS¼Glaucoma Probability Score; HR¼ hazard ratio;
HRT ¼ Heidelberg Retina Tomograph; IOP ¼ intraocular
pressure; MRA ¼ Moorfields regression analysis; OAG ¼ open-
angle glaucoma; PSD ¼ pattern standard deviation.
The hazard ratios of all the covariates are reported as ranges
among the various models. The P value result was always <.05
or >.05.One multivariate model was then run for each single
HRT parameter to test the independent relationship of
each HRT parameter with OAG (for a total of 11 models).
Factors significantly predictive of the development of
OAG in the multivariate model (without HRT disc area)
included rim area, rim volume, C/D area ratio, C/D linear
ratio, cup depth, cup shape measure, and FSM function
outside normal limits. In this model, older age, higher
IOP, and thinner CCT were also significantly predictive
of the development of OAG (Table 4).
Factors significantly predictive of the development of
OAG in the multivariate model (with HRT disc area as co-
variate) included cup area, rim area, cup volume, rim vol-
ume, C/D area ratio, C/D linear ratio, cup depth,
maximum cup depth, cup shape measure, and FSM func-
tion outside normal limits. In this model, older age, higher
IOP, and thinner CCT were also significantly predictive of
the development of OAG (Table 5). MRA results outside
normal limits were not included in this model, as MRA is
based on the evaluation of rim area as a function of disc
area. However, in a secondary analysis, which also included
MRA, no statistically significant association was found be-
tween MRA and the development of glaucoma (HR 1.9;
95% CI 0.9–4.0; P ¼ .091).270 AMERICAN JOURNAL OFThe survival curves of the summary results of HRT anal-
ysis—FSM, GPS global result, and MRA—show that the
univariate cumulative probability of developing OAG
within a time span of 5 years among subjects with an
abnormal HRT summary result vs those with a normal
HRT summary result at baseline was significantly higher
in the case of an abnormal FSM (x2 - log rank: 12.48;
P ¼ .0004) and an abnormal MRA (x2 - log rank: 6.33;
P ¼ .0119), but not in the case of an abnormal GPS (x2 -
log rank: 1.34; P ¼ .247) (Figures 1–3).DISCUSSION
IT IS DEEMED IMPORTANT TO ASSESS THE PREDICTIVE
(prognostic) factors for the development of OAG in order
to identify the OHT patients at greater risk for future pro-
gression to OAG who may benefit from a closer follow-up
evaluation and/or a prompt therapeutic approach.
The data collected from the EGPS HRT ancillary study
and reported in this manuscript provide information aboutFEBRUARY 2015OPHTHALMOLOGY
TABLE 5. Multivariate Hazard Ratios and 95% Confidence
Intervals for the Development of Open-Angle Glaucoma
(Average of the Eyes), Including the Model Age, Baseline
Intraocular Pressure, Central Corneal Thickness, Pattern
Standard Deviation, and Heidelberg Retina Tomograph
Disc Area
HRT Parameter HR (95% CI) P
Cup area (per 0.3 mm2 greater) 1.33 (1.08–1.64) .008
Rim area (per 0.2 mm2 greater) 0.75 (0.61–0.93) .008
Cup volume (per 0.1 mm2 greater) 1.30 (1.05–1.61) .017
Rim volume (per 0.1 mm3 greater) 0.80 (0.65–0.99) .041
C/D area (per 0.1 greater) 1.43 (1.14–1.80) .002
C/D linear (per 0.1 greater) 1.43 (1.13–1.80) .003
Cup depth (per 0.1 mm greater) 1.64 (1.21–2.23) .002
Maximum cup depth
(per 0.1 mm greater)
1.18 (1.01–1.36) .031
Cup shape measure (per 0.1 greater) 1.86 (1.16–2.99) .009
FSM outside normal limits 2.51 (1.41–4.35) .001
GPS global outside normal limits 0.98 (0.47–2.03) .95
Age (per 10 y older) 1.36–1.58 <.05
Baseline IOP (per 1 mm Hg higher) 1.18–1.22 <.05
CCT (per 40 mm thinner) 1.51–1.60 <.05
PSD (per 0.2 dB greater) 1.02–1.19 >.05
HRT disc area (per 0.4 mm2 greater) 0.32–1.34 >.05
CCT ¼ central corneal thickness; C/D ¼ cup-to-disc; CI ¼
confidence interval; FSM ¼ Frederick Mikelberg discriminant
function; GPS¼Glaucoma Probability Score; HR¼ hazard ratio;
HRT ¼ Heidelberg Retina Tomograph; IOP ¼ intraocular pres-
sure; OAG ¼ open-angle glaucoma; PSD ¼ pattern standard
deviation.
The hazard ratios of all the covariates are reported as ranges
among the various models. The P value result was always <.05
or >.05.
FIGURE 1. Kaplan-Meier plot of the univariate cumulative
probability of developing open-angle glaucoma by the Frederick
Mikelberg discriminant function result outside normal limits
(dashed lines) compared with those not outside normal limits
(bold line). The difference is statistically significant (x2 - log
rank: 12.48; P[ .0004).
FIGURE 2. Kaplan-Meier plot of the univariate cumulative
probability of developing open-angle glaucoma by theMoorfields
regression analysis result outside normal limits (dashed lines)
compared with those not outside normal limits (bold line).
The difference is statistically significant (x2 - log rank: 6.33;
P[ .0119).the HRT-based predictive factors for the development of
OAG within 5 years in OHT patients.
In the EGPS, after adjusting for the treatment arm, age,
PSD, CCT, and HRT disc area, the HRT measurements
that significantly predicted the development of OAG
over a 5-year period were cup area, cup volume, C/D
area, C/D linear, cup depth, maximum cup depth, cup
shape measure, rim area, rim volume, and the FSM multi-
discriminant function.
TheOHTS is the firstmulticenter, long-termclinical trial
on OHT patients to have evaluated their data for HRT-
based predictive factors in a subset of the original sample.
Two different papers have reported the OHTSHRT predic-
tive value for the development of POAG: 1 within 5 years35
and another within 12 years.36 If the predictive factors
observed in the EGPS and those observed in the OHTS
are compared, it is quite clear that the 2 studies had several
consistent results (Table 6). Somedifferences in terms of the
absolute values of the HRsmay be explained by some proto-
col differences between the 2 studies, by population differ-
ences, and by differences in the follow-up time.VOL. 159, NO. 2 EXOGENOUS FUNGAL ENDOPHTHALMAs a matter of fact, most of the stereometric variables
were significantly predictive for the development of
OAG in OHTS. The only difference between the EGPS
and the OHTS stereometric variables results was related
to cup shape measure that our study confirmed as being a
statistically and clinically significant marker for the devel-
opment of OAG, whereas the OHTS did not. Cup shape
measure has been identified from several studies as one of
the most reliable stereometric HRT measurement for the
early identification of glaucoma-related abnormality of
the optic disc.20,48–53 Cup shape measure, previously
known as ‘‘third momentum,’’ describes the shape of the271ITIS ANTIFUNGAL SUSCEPTIBILITIES
FIGURE 3. Kaplan-Meier plot of the univariate cumulative
probability of developing open-angle glaucoma by the Glaucoma
Probability Score result outside normal limits (dashed lines)
compared with those not outside normal limits (bold line).
The difference is not statistically significant (x2 - log rank:
1.34; P[ .247).optic disc cupping and is inherent in the FSM and RB
discriminant formulas.
Interestingly, and in total agreement with the OHTS, no
‘‘RNFL’’-based HRT measurement was predictive of OAG
development. RNFL thickness and RNFL cross-sectional
area have always been improperly referred to as RNFL pa-
rameters. These measurements refer to the position of the
reference plane along the ‘‘z’’ axis, which is, by default,
localized 50 mm below the surface at the papillomacular
bundle localized along the contour line.54 For this reason,
whatever is above the reference plane and along the con-
tour line cannot reflect the anatomic region of the retina
known as ‘‘RNFL.’’ Although the RNFL becomes thinner
in glaucomatous eyes, it is thus conceivable that the ‘‘surro-
gate measurement of RNFL’’ performed by the HRT is un-
able to properly identify its glaucomatous thinning. HVC is
instead the measure of height variability of the topographic
surface along the contour line. It should somewhat refer to
the modulation of RNFL height along the optic disc border
(identified by the contour line). Apparently, the same crit-
icisms referring to the RNFL-related HRT parameters may
hold true for HVC.
The rim- and cup-related parameters have been indicated
as good markers for early glaucoma in the vast majority of
the HRT-related investigations.18–21,23,27,29,35,36,49–52 In
our study, however, cup area was a significant predictor
for OAG development only when the multivariate
analysis included HRT disc area in the model. Rim and
cup areas are significantly correlated with disc area in
normal eyes, both in morphometric studies44,45 and in
HRT studies.46,47,55–58 This suggests that both cup area
and rim area should increase their predictive value for the
development of OAG by taking disc area into account.272 AMERICAN JOURNAL OFThis hypothesis has been clearly confirmed for cup area
but not for rim area in our study, suggesting that rim area
or rim-related variables may be more easily handled by
the ophthalmologist in order to better estimate the individ-
ual risk profile of the OHT patient.
The multidiscriminant functions FSM16 and RB,25 as
well as the classification systems such as the MRA21 and
the GPS,24 have been developed in order to achieve an ac-
curate and simple clinical identification of abnormal (glau-
comatous) discs. Several cross-sectional studies have
investigated their diagnostic ability, often reporting good
results.16,19,21,24,25,27,59 Other longitudinal studies have
reported a significant predictability for the development
of POAG in the case of MRA,60,61 but not for GPS.60 In
the OHTS both FSM and MRA were significantly predic-
tive for the development of POAG at 5 years,35 whereas
MRA and GPS were significantly predictive for the devel-
opment of POAG at 12 years.36 In the EGPS, with a follow-
up of 5 years, FSM was significantly predictive for the
development of OAG, whereas MRA and GPS were not
in the multivariate models including age, baseline IOP,
CCT, and PSD (with and without HRT disc area). Howev-
er, MRA was significantly predictive in univariate analysis,
and the survival curve showed that the univariate cumula-
tive probability of developing OAGwithin a time span of 5
years among subjects with an abnormal MRA result vs
those with a normal MRA result at baseline was signifi-
cantly higher (x2 - log rank test: 6.33; P ¼ .0119)
(Figure 2). Moreover, if we focus on the graphs of the sur-
vival curves of MRA and GPS reported in this study (on a
time span of 5 years) (Figures 2 and 3) and on those
published by the OHTS (on a time span of 12 years),36
and compare the graphs at the time point of 60 months,
it seems quite clear that the separation of the 2 cumulative
curves in the 2 graphs of the 2 studies are very similar in the
case of both MRA and GPS. We think that at the time
point of 60 months the results for MRA and GPS in the
OHTS and EGPS are quite the same (ie, GPS was not
significantly predictive of the development of POAG also
in the OHTS). Although this hypothesis cannot be math-
ematically confirmed by us, it cannot be ruled out.
It is always difficult to compare results from different
studies, given differences in the selection of the sample,
in the sample size, in the definition of the disease,62 in
the methodology, and in the follow-up (in case of longitu-
dinal studies). In the case of HRT studies, other sources of
variability may add to the results, such as the quality of the
images, the definition of the contour line (which is manu-
ally drawn), and the influence of disc size on MRA, GPS,
RB, and FSM discriminant functions.46,47,63,64 The EGPS
is the largest cohort of OHT white patients studied by
means of HRT and followed up for 5 years. The
definition of OAG is based on standardized criteria,
established before the start of the trial.39 Assessment of im-
age quality was performed by means of the automatic qual-
ity control of the software according to the recommendedFEBRUARY 2015OPHTHALMOLOGY
TABLE 6. Multivariate Hazard Ratios and 95% Confidence Intervals for the Development of Open-Angle Glaucoma (Average of the
Eyes), Including theModel Age, Baseline Intraocular Pressure, Central Corneal Thickness, Pattern Standard Deviation, and Heidelberg
Retina Tomograph Disc Area, in the European Glaucoma Prevention Study and Hazard Ratios Reported by the Ocular Hypertensive
Treatment Study
HRT Parameter
EGPS 5 Years OHTS 5 Years35 OHTS 12 Years36
HR (95% CI) HR (95% CI) HR (95% CI)
Cup area (per 0.3 mm2 greater) 1.33 (1.08–1.64) 1.21 (0.96–1.53) 1.47 (1.21–1.79)
Rim area (per 0.2 mm2 greater) 0.75 (0.61–0.93) 0.57 (0.42–0.78) 0.46 (0.36–0.59)
Cup volume (per 0.1 mm2 greater) 1.30 (1.05–1.61) 1.20 (1.01–1.43) 1.40 (1.23–1.60)
Rim volume (per 0.1 mm3 greater) 0.80 (0.65–0.99) 0.65 (0.47–0.91) 0.53 (0.39–0.72)
C/D area (per 0.1 greater) 1.43 (1.14–1.80) 1.25 (1.02–1.53) 1.64 (1.36–1.96)
C/D linear (per 0.1 greater) 1.43 (1.13–1.80) - 1.71 (1.36–2.15)
Cup depth (per 0.1 mm greater) 1.64 (1.21–2.23) 1.60 (1.15–2.22) 1.93 (1.50–2.49)
Maximum cup depth (per 0.1 mm greater) 1.18 (1.01–1.36) - -
Cup shape measure (per 0.1 greater) 1.86 (1.16–2.99) 1.02 (0.62–1.67) 1.33 (0.94–1.88)
FSM outside normal limits 2.51 (1.41–4.35) 2.54 (1.31–4.90) -
GPS global outside normal limits 0.98 (0.47–2.03) - 3.51 (1.83–6.73)
MRA result outside normal limits 1.75 (0.87–3.51) 2.39 (1.02–5.62) 3.90 (2.09–7.28)
C/D ¼ cup-to-disc; CI ¼ confidence interval; EGPS ¼ European Glaucoma Prevention Study; FSM ¼ Frederick Mikelberg discriminant
function; GPS¼Glaucoma Probability Score; HR¼ hazard ratio; HRT¼Heidelberg Retina Tomograph; MRA¼Moorfields regression analysis;
OAG ¼ open-angle glaucoma; OHTS ¼ Ocular Hypertension Treatment Study.
TABLE 7. Multivariate Hazard Ratios and 95% Confidence
Intervals of the Clinical Predictive Factors for the
Development of Open-Angle Glaucoma (Average of the Eyes)
Reported in the Original European Glaucoma Prevention
Study12 and Observed in the Present Study
Parameter
EGPS EGPS HRT Substudy
HR (95% CI) HR (95% CI)
Age (per decade) 1.32 (1.04–1.69) 1.52 (1.05–2.19)
IOP, baseline (per mm Hg) 1.07 (0.94–1.22) 1.10 (0.93–1.30)
CCT (per 40 mm thinner) 1.32 (1.05–1.67) 1.71 (1.21–2.41)
Vertical C/D ratio
(per 0.1 larger)
1.34 (1.14–1.58) 1.88 (1.38–2.58)
PSD (per 0.2 dB greater) 1.66 (1.15–2.38) 1.53 (0.92–2.56)
CCT ¼ central corneal thickness; C/D ¼ cup-to-disc; CI ¼
confidence interval; EGPS ¼ European Glaucoma Prevention
Study; HR ¼ hazard ratio; IOP ¼ intraocular pressure; OAG ¼
open-angle glaucoma; PSD ¼ pattern standard deviation.criteria (to reject images): images whose standard deviation
was greater than 50 mm were automatically excluded.37
The optic disc margin was outlined by 1 experienced exam-
iner and each outline of the optic disc was reviewed by a
second experienced examiner (with differences of opinion
resolved by consensus).37 A second independent image
quality control step was performed at the OHTS CSLO
Reading Center, using the same review criteria that had
been used for the OHTS CSLO Ancillary Study.34–36
Differently from the OHTS, which included data for
both eyes of the participant in the model, and used theVOL. 159, NO. 2 EXOGENOUS FUNGAL ENDOPHTHALMmethod of Lee and associates65 to adjust for the correlation
of the 2 eyes from the same participant, the EGPS averaged
the measurements of the 2 eyes in order to be consistent
with the methodology applied in the assessment of the
baseline clinical predictive factors,12 and flagged as
‘‘outside the normal limits’’ all the cases whose classifica-
tion was outside in 1 eye and not outside normal limits in
the fellow eye. Moreover, the mean HRT disc size of the
EGPS sample is slightly larger than the mean HRT disc
area reported in the OHTS.35 These discrepancies may
have contributed to the slightly different results reported
for some variables in the 2 studies.
This study may have some limitations as well, and both
the possible inadequate representativeness of the original
EGPS population and technical concerns related to HRT
protocol have been previously addressed and discussed.37
To better address the issue of inadequate representative-
ness, it is of note that the HRs of the predictive factors pre-
viously reported in the EGPS (age, IOP, CCT, vertical C/D
ratio, and PSD)12 and those observed in this subset are
similar, but tend to indicate that this subset of the original
EGPS population may be at higher risk to develop OAG
(Table 7).
The results of the EGPS HRT substudy may be clinically
relevant as they support the use of HRT in the clinical
practice, as a useful clinical tool to perform optic disc topo-
graphic measurements in OHT patients who may have a
high risk to develop OAG. Although it has been consis-
tently shown that an accurate clinical evaluation of the op-
tic disc with an estimate of the C/D ratio may be sufficient
to help the clinician in estimating the individual OHT pa-
tient’s risk to develop OAG within the next 5 years, the273ITIS ANTIFUNGAL SUSCEPTIBILITIES
results of this study, in agreement with those of the OHTS,
seem to indicate that several HRT parameters/classifica-
tion systems are statistically and clinically significant prog-
nostic factors for the development of OAG. This does not
mean that HRT replaces clinical judgment of the optic
disc. Instead it supports the implementation of HRT in
the daily clinical practice, as it has been recently shown274 AMERICAN JOURNAL OFthat its diagnostic ability outperforms the diagnostic ability
of general ophthalmologists.66
Lastly, the results of the EGPS HRT substudy will
contribute to the ongoing OHTS-EGPS HRT collabora-
tive study with the aim of providing a further refinement
of the risk model previously established by the collabora-
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